npj Precision Oncology (Aug 2022)

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment

  • Xuebing Shi,
  • Zhixuan Li,
  • Renqi Yao,
  • Qingbao Cheng,
  • Wei Li,
  • Rui Wu,
  • Zhihua Xie,
  • Yanjing Zhu,
  • Xinyao Qiu,
  • Shuai Yang,
  • Tao Zhou,
  • Ji Hu,
  • Yangqianwen Zhang,
  • Tong Wu,
  • Yan Zhao,
  • Yani Zhang,
  • Jianmin Wu,
  • Hongyang Wang,
  • Xiaoqing Jiang,
  • Lei Chen

DOI
https://doi.org/10.1038/s41698-022-00300-9
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Immunotherapies have been explored in treating solid tumors, albeit with disparate clinical effects in distinct cancer types. Systematic interrogation of immune cells in the tumor microenvironment (TME) is vital to the prediction of immunotherapy response and the development of innovative immunotherapeutics. To comprehensively characterize the immune microenvironment in advanced biliary tract cancer (BTC), we utilized single-cell RNA sequencing in unselected viable cells from 16 matched samples, and identified nineteen cell subsets from a total of 45,851 cells, in which exhausted CD8+ T cells, macrophages, and dendritic cells (DCs) in BTC were shown to augment and communicate within the TME. Transcriptional profiles coupled with T cell receptor (TCR) sequences revealed that exhausted CD8+ T cells retained clonal expansion and high proliferation in the TME, and some of them highly expressed the endoplasmic reticulum stress (ER) response gene, XBP1, indicating the role of ER stress in remodeling TME. Functional assays demonstrated that XBP1 and common immune checkpoints (PD1, TIGIT) were significantly upregulated in CD8+ T cells cocultured within the TME of BTC cells (GBC-SD, HCCC-9810). When treating the coculture groups with the specific inhibitor of IRE1α-XBP1 (4μ8C), the downregulation of TIGIT was observed in the treatment group. Collectively, comprehensive transcriptome profiling provides deep insights into the immune atlas in advanced BTC, which might be instrumental in exploring innovative immunotherapy strategies.